FIGURE

Fig. 4

ID
ZDB-FIG-240605-72
Publication
Ye et al., 2022 - c-myb is involved in CML progression and is a therapeutic target in the zebrafish CML model
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Combined treatment with flavopiridol and imatinib had a better response in Tg(hsp70:p210BCR/ABL1);c-mybhyper. (A–H) WISH of lcp1 expression in the drug-treated larvae at 4.5 dpf. After heat shock treatment, 2.5 dpf Tg(hsp70:p210BCR/ABL1) and Tg(hsp70:p210BCR/ABL1);c-mybhyper were treated for 48 h with 1‰ DMSO control, 0.1 μmol/L flavopiridol, 80 μmol/L imatinib, or 0.1 μmol/L flavopiridol combined with 80 μmol/L imatinib. (I), Quantification of numbers of 4.5 dpf lcp1+ cells in CHT (Tg(hsp70:p210BCR/ABL1) DMSO, n = 30; Tg(hsp70:p210BCR/ABL1) imatinib, n = 29; Tg(hsp70:p210BCR/ABL1) flavopiridol, n = 30; Tg(hsp70:p210BCR/ABL1) flavopiridol+imatinib, n = 29; Tg(hsp70:p210BCR/ABL1);c-mybhyper DMSO, n = 30; Tg(hsp70:p210BCR/ABL1);c-mybhyper imatinib, n = 31; Tg(hsp70:p210BCR/ABL1);c-mybhyper flavopiridol, n = 30; Tg(hsp70:p210BCR/ABL1);c-mybhyper flavopiridol+imatinib, n = 27). Scale bar, 100 μm; applies to panels (A–H).

Expression Data
Gene:
Fish:
Conditions:
Anatomical Term:
Stage: Day 4

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage: Day 4

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Animal Model Exp Med
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.